Yet another lawsuit is taking aim at the Affordable Care Act, and 61 U.S. medical organizations have joined forces to speak out.

Two companies serving medical imagers just had products cleared for marketing in the U.S.

Bob Still, executive director of the Radiologist Business Management Association, believes CMS’s proposed physician fee schedule for 2023 will harm vulnerable populations and seriously injure U.S. healthcare. Hear him out.

Radiology researchers from six leading medical schools have laid out some attuned and readily adoptable strategies for groups challenged to prosper in a time of difficult reimbursement dynamics.

Two weeks ago CMS proposed a 2023 physician fee schedule (PFS) that stands to slash pay to U.S. diagnostic radiologists by 3% and interventionalists by 4%. This week the U.K.’s National Health Service put that country’s radiologists in a similar bind.

A retrospective analysis of cross-sectional venograms shows only 4.5% of a teaching hospital’s COVID-vaccinated patients had a clotting condition in early 2021. Meanwhile the rate for the unvaccinated was 10.1%.

When counseling patients with architectural distortion on digital breast tomosynthesis (DBT) but no signs of malignancy on biopsy, mammographers should raise imaging alone as a sound option for surveillance.

Last week the Centers for Medicare and Medicaid Services posted a tentative Physician Fee Schedule for 2023. Initial reactions from radiology were muted. That changed this Wednesday.